Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ANG1:
-
Angiopoietin 1
- ANG2:
-
Angiopoietin 2
- CD:
-
Cluster of differentiation
- GFP:
-
Green fluorescent protein
- HGF:
-
Hepatic growth factor
- hUCMSC:
-
Human umbilical cord mesenchymal stem cells
- HUVEC:
-
Human umbilical vein endothelial cells
- PBS:
-
Phosphate buffer saline
- PIGF:
-
Placental growth factor
- TGF-β:
-
Transforming growth factor beta
- VEGF:
-
Vascular endothelial growth factor
References
Ahmed, L., & Al-Massri, K. (2022). New approaches for enhancement of the efficacy of mesenchymal stem cell-derived exosomes in cardiovascular diseases. Tissue Engineering and Regenerative Medicine, 19(6), 1129–1146.
Akan, E., Cetinkaya, B., Kipmen-Korgun, D., Ozmen, A., Koksoy, S., Mendilcioğlu, İ., et al. (2021). Effects of amnion derived mesenchymal stem cells on fibrosis in a 5/6 nephrectomy model in rats. Biotechnic & Histochemistry, 96(8), 594–607.
Arslan, F., Lai, R. C., Smeets, M. B., Akeroyd, L., Choo, A., Aguor, E. N., et al. (2013). Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Research, 10(3), 301–312.
Assis, A. C., Carvalho, J. L., Jacoby, B. A., Ferreira, R. L., Castanheira, P., Diniz, S. O., et al. (2010). Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart. Cell Transplantation, 19(2), 219–230.
Cao, Y., Ji, C., & Lu, L. (2020). Mesenchymal stem cell therapy for liver fibrosis/cirrhosis. Annals of Translational Medicine, 8(8), 562.
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315–317.
Eggenhofer, E., Benseler, V., Kroemer, A., Popp, F. C., Geissler, E. K., Schlitt, H. J., et al. (2012). Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Frontiers in Immunology, 3, 297.
Ge, L., Xun, C., Li, W., Jin, S., Liu, Z., Zhuo, Y., et al. (2021). Extracellular vesicles derived from hypoxia-preconditioned olfactory mucosa mesenchymal stem cells enhance angiogenesis via miR-612. Journal of Nanobiotechnology, 19(1), 380.
Gong, M., Yu, B., Wang, J., Wang, Y., Liu, M., Paul, C., et al. (2017). Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis. Oncotarget, 8(28), 45200–45212.
Han, Y., Ren, J., Bai, Y., Pei, X., & Han, Y. (2019). Exosomes from hypoxia-treated human adipose-derived mesenchymal stem cells enhance angiogenesis through VEGF/VEGF-R. The International Journal of Biochemistry & Cell Biology, 109, 59–68.
Helwa, I., Cai, J., Drewry, M. D., Zimmerman, A., Dinkins, M. B., Khaled, M. L., et al. (2017). A Comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents. PLoS One, 12(1), e0170628.
Heo, J. S., & Kim, S. (2022). Human adipose mesenchymal stem cells modulate inflammation and angiogenesis through exosomes. Scientific Reports, 12(1), 2776.
Huang, C., Luo, W., Wang, Q., Ye, Y., Fan, J., Lin, L., et al. (2021). Human mesenchymal stem cells promote ischemic repairment and angiogenesis of diabetic foot through exosome miRNA-21-5p. Stem Cell Research, 52, 102235.
Ji, S., Xin, H., Li, Y., & Su, E. J. (2018). FMS-like tyrosine kinase 1 (FLT1) is a key regulator of fetoplacental endothelial cell migration and angiogenesis. Placenta, 70, 7–14.
Komaki, M., Numata, Y., Morioka, C., Honda, I., Tooi, M., Yokoyama, N., et al. (2017). Exosomes of human placenta-derived mesenchymal stem cells stimulate angiogenesis. Stem Cell Research & Therapy, 8(1), 219.
Kong, X., Bu, J., Chen, J., Ni, B., Fu, B., Zhou, F., et al. (2021). PIGF and Flt-1 on the surface of macrophages induces the production of TGF-β1 by polarized tumor-associated macrophages to promote lung cancer angiogenesis. European Journal of Pharmacology, 912, 174550.
Lai, R. C., Arslan, F., Lee, M. M., Sze, N. S., Choo, A., Chen, T. S., et al. (2010). Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research, 4(3), 214–222.
Lee, H. K., Chauhan, S. K., Kay, E., & Dana, R. (2011). Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway. Blood, 117(21), 5762–5771.
Lee, J. K., Park, S. R., Jung, B. K., Jeon, Y. K., Lee, Y. S., Kim, M. K., et al. (2013). Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One, 8(12), e84256.
Li, M., Zeringer, E., Barta, T., Schageman, J., Cheng, A., & Vlassov, A. V. (2014). Analysis of the RNA content of the exosomes derived from blood serum and urine and its potential as biomarkers. Philosophical Transactions of the Royal Society of London Series B, Biological Sciences, 369(1652), 20130502.
Li, L., Cheng, D., An, X., Liao, G., Zhong, L., Liu, J., et al. (2021). Mesenchymal stem cells transplantation attenuates hyperuricemic nephropathy in rats. International Immunopharmacology, 99, 108000.
Liang, W., Han, B., Hai, Y., Sun, D., & Yin, P. (2021). Mechanism of action of mesenchymal stem cell-derived exosomes in the intervertebral disc degeneration treatment and bone repair and regeneration. Frontiers in Cell and Developmental Biology, 9, 833840.
Lötvall, J., Hill, A. F., Hochberg, F., Buzás, E. I., Di Vizio, D., Gardiner, C., et al. (2014). Minimal experimental requirements for definition of extracellular vesicles and their functions: A position statement from the International Society for Extracellular Vesicles. Journal of Extracellular Vesicles, 3, 26913.
Masterson, C. H., Tabuchi, A., Hogan, G., Fitzpatrick, G., Kerrigan, S. W., Jerkic, M., et al. (2021). Intra-vital imaging of mesenchymal stromal cell kinetics in the pulmonary vasculature during infection. Scientific Reports, 11(1), 5265.
Mojzisch, A., & Brehm, M. A. (2021). The manifold cellular functions of von Willebrand factor. Cell, 10(9), 2351.
Panda, B., Sharma, Y., Gupta, S., & Mohanty, S. (2021). Mesenchymal stem cell-derived exosomes as an emerging paradigm for regenerative therapy and Nano-medicine: A comprehensive review. Life (Basel, Switzerland), 11(8), 784.
Qiu, X., Liu, J., Zheng, C., Su, Y., Bao, L., Zhu, B., et al. (2020). Exosomes released from educated mesenchymal stem cells accelerate cutaneous wound healing via promoting angiogenesis. Cell Proliferation, 53(8), e12830.
Randi, A. M., & Laffan, M. A. (2017). Von Willebrand factor and angiogenesis: Basic and applied issues. Journal of Thrombosis and Haemostasis, 15(1), 13–20.
Ratajczak, M. Z., Kucia, M., Jadczyk, T., Greco, N. J., Wojakowski, W., Tendera, M., et al. (2012). Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: Can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia, 26(6), 1166–1173.
Rim, K. T., & Kim, S. J. (2016). Quantitative analysis of exosomes from murine lung cancer cells by flow cytometry. Journal of Cancer Prevention, 21(3), 194–200.
Saito, Y. (2021). The role of the PlGF/Flt-1 signaling pathway in the cardiorenal connection. Journal of Molecular and Cellular Cardiology, 151, 106–112.
Shabbir, A., Cox, A., Rodriguez-Menocal, L., Salgado, M., & Van Badiavas, E. (2015). Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro. Stem Cells and Development, 24(14), 1635–1647.
Shibuya, M. (2006). Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): A dual regulator for angiogenesis. Angiogenesis, 9(4), 225–230; discussion 31.
Starke, R. D., Ferraro, F., Paschalaki, K. E., Dryden, N. H., McKinnon, T. A., Sutton, R. E., et al. (2011). Endothelial von Willebrand factor regulates angiogenesis. Blood, 117(3), 1071–1080.
Sun, Y., Ju, Y., & Fang, B. (2022). Exosomes from human adipose-derived mesenchymal stromal/stem cells accelerate angiogenesis in wound healing: Implication of the EGR-1/lncRNA-SENCR/DKC1/VEGF-A axis. Human Cell, 35(5), 1375–1390.
Takeuchi, R., Katagiri, W., Endo, S., & Kobayashi, T. (2019). Exosomes from conditioned media of bone marrow-derived mesenchymal stem cells promote bone regeneration by enhancing angiogenesis. PLoS One, 14(11), e0225472.
Théry, C., & Witwer, K. W. (2018). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. Journal of Extracellular Vesicles, 7(1), 1535750.
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology, 9(6), 654–659.
Webber, J., & Clayton, A. (2013). How pure are your vesicles? Journal of Extracellular Vesicles, 2. https://doi.org/10.3402/jev.v2i0.19861
Wu, M. C., & Meng, Q. H. (2021). Current understanding of mesenchymal stem cells in liver diseases. World Journal of Stem Cells, 13(9), 1349–1359.
Xue, C., Li, X., Ba, L., Zhang, M., Yang, Y., Gao, Y., et al. (2021). MSC-derived exosomes can enhance the angiogenesis of human brain MECs and show therapeutic potential in a mouse model of Parkinson’s disease. Aging and Disease, 12(5), 1211–1222.
Yan, C., Xv, Y., Lin, Z., Endo, Y., Xue, H., Hu, Y., et al. (2022). Human umbilical cord mesenchymal stem cell-derived exosomes accelerate diabetic wound healing via ameliorating oxidative stress and promoting angiogenesis. Frontiers in Bioengineering and Biotechnology, 10, 829868.
Yin, K., Wang, S., & Zhao, R. C. (2019). Exosomes from mesenchymal stem/stromal cells: A new therapeutic paradigm. Biomarker Research, 7(1), 8.
Yu, M., Liu, W., Li, J., Lu, J., Lu, H., Jia, W., et al. (2020). Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway. Stem Cell Research & Therapy, 11(1), 350.
Zhang, Y., Hao, Z., Wang, P., Xia, Y., Wu, J., Xia, D., et al. (2019). Exosomes from human umbilical cord mesenchymal stem cells enhance fracture healing through HIF-1α-mediated promotion of angiogenesis in a rat model of stabilized fracture. Cell Proliferation, 52(2), e12570.
Acknowledgments
We thank SCI Biobank for providing mesenchymal stem cells used in this study.
Author’s Contributions
All authors equally contributed in this work. All authors read and approved the final version of the manuscript for submission.
Availability of Data and Materials
Data and materials used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Ethics Approval and Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare that they have no competing interests.
Funding
This research is funded by Vietnam National University, Ho Chi Minh City (VNU-HCM) under grant number 562-2020-18-03.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Huynh, P.D., Van Pham, P., Vu, N.B. (2023). Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Enhance Angiogenesis Through Upregulation of the VWF and Flk1 Genes in Endothelial Cells. In: Pham, P.V. (eds) Advances in Mesenchymal Stem Cells and Tissue Engineering. ICRRM 2023. Advances in Experimental Medicine and Biology(). Springer, Cham. https://doi.org/10.1007/5584_2023_768
Download citation
DOI: https://doi.org/10.1007/5584_2023_768
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-38612-1
Online ISBN: 978-3-031-38613-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)